Aarhus University Hospital in Denmark Purchases NBS System from Nexstim Plc
(Thomson Reuters ONE) -
Press release, Helsinki, 24 April 2017 at 3 pm
Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), a medical
technology company developing and marketing pioneering navigated non-invasive
brain stimulation systems for both therapeutic and diagnostic applications,
announces that Aarhus University Hospital, Denmark has recently purchased a
Navigated Brain Stimulation (NBS) System.
The NBS System at Aarhus University Hospital will be used for diagnostic brain
mapping for the treatment of brain tumours and other neurologic related
disorders.
The neurosurgeons at Aarhus University Hospital Dr. Anders Rosendal Korshoj and
Dr. Gorm von Oettingen commented: "We are excited with the acquisition of
Nexstim NBS and the unique diagnostic information it provides. We expect to be
able to operate 25% more patients with central area tumours due to the ability
of the Nexstim system to correctly plan these high-risk surgeries."
Commenting on this news, Henri Hannula, VP Sales Europe said: "We are delighted
that one of the leading neurosurgical departments in Denmark has decided to
acquire our unique brain mapping system. We look forward to co-operating with
the team at Aarhus University Hospital and adding them to our growing
international brain mapping customer group in neurosurgery."
NEXSTIM PLC
Martin Jamieson, Chairman and CEO
Further information is available on the website www.nexstim.com or by telephone:
Nexstim +447715163942
Martin Jamieson, Chairman and CEO martin.jamieson(at)nexstim.com
Citigate Dewe Rogerson +44 (0)207 2821066
Katja Stout katja.stout(at)citigatedr.co.uk
About Nexstim Plc
Nexstim is a medical technology company a medical technology company developing
and marketing pioneering navigated non-invasive brain stimulation systems for
both therapeutic (NBT® system) and diagnostic (NBS system) applications.
Nexstim's NBS system is the only FDA cleared and CE marked system based on
navigated Transcranial Magnetic Stimulation (nTMS) for the pre-surgical mapping
of the speech and motor cortices of the brain.
Based on the same technology platform, the Company has developed the Navigated
Brain Therapy (NBT®) which is CE marked for the treatment of stroke, major
depression and chronic neuropathic pain. The NBT® system is currently in a
supplemental Phase III study, E-FIT trial, which will recruit 60 patients. The
trial is expected to complete in Q1 2018 allowing Nexstim to file for FDA
clearance in April 2018. FDA clearance would allow Nexstim to start marketing
and selling its NBT® system for stroke rehabilitation in the USA.
Nexstim shares are listed on the Nasdaq First North Finland and Nasdaq First
North Sweden. For more information please visit www.nexstim.com
About Aarhus University Hospital
Aarhus University Hospital is a highly-specialized hospital in Central Denmark
Region, one of five Danish regions.
The Department of Neurosurgery at Aarhus University Hospital is one of the
leading neurosurgical departments in Denmark. The department performs general
neurosurgery and highly specialized neurosurgical treatments to patients in
Central Denmark Region, other Danish regions and to patients from abroad.
Excellence in patient treatment is the key focus of the department and this is
supported by internationally renowned research and collaborations.
Aarhus University Hospital Purchases NBS System from Nexsti:
http://hugin.info/138152/R/2098014/794486.pdf
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Nexstim Oyj via GlobeNewswire
Unternehmensinformation / Kurzprofil:
Datum: 24.04.2017 - 14:00 Uhr
Sprache: Deutsch
News-ID 537849
Anzahl Zeichen: 4487
contact information:
Town:
Helsinki
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 166 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Aarhus University Hospital in Denmark Purchases NBS System from Nexstim Plc"
steht unter der journalistisch-redaktionellen Verantwortung von
Nexstim Oyj (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
